HUP0000397A3 - The use of glucocorticoid substances pasessing a minimal systemic effect for producing pharmaceutical composition for the treatment of joint inflammation - Google Patents
The use of glucocorticoid substances pasessing a minimal systemic effect for producing pharmaceutical composition for the treatment of joint inflammationInfo
- Publication number
- HUP0000397A3 HUP0000397A3 HU0000397A HUP0000397A HUP0000397A3 HU P0000397 A3 HUP0000397 A3 HU P0000397A3 HU 0000397 A HU0000397 A HU 0000397A HU P0000397 A HUP0000397 A HU P0000397A HU P0000397 A3 HUP0000397 A3 HU P0000397A3
- Authority
- HU
- Hungary
- Prior art keywords
- pasessing
- glucocorticoid
- substances
- treatment
- pharmaceutical composition
- Prior art date
Links
- 206010003246 arthritis Diseases 0.000 title 1
- 239000003862 glucocorticoid Substances 0.000 title 1
- 208000018937 joint inflammation Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 230000009885 systemic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9604751A SE9604751D0 (sv) | 1996-12-20 | 1996-12-20 | New therapy |
| PCT/SE1997/002124 WO1998027987A1 (en) | 1996-12-20 | 1997-12-16 | New treatment for joint inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0000397A2 HUP0000397A2 (hu) | 2000-10-28 |
| HUP0000397A3 true HUP0000397A3 (en) | 2001-01-29 |
Family
ID=20405107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0000397A HUP0000397A3 (en) | 1996-12-20 | 1997-12-16 | The use of glucocorticoid substances pasessing a minimal systemic effect for producing pharmaceutical composition for the treatment of joint inflammation |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6432937B1 (hu) |
| EP (1) | EP0957922A1 (hu) |
| JP (1) | JP2001507024A (hu) |
| KR (1) | KR20000069594A (hu) |
| AU (1) | AU5502598A (hu) |
| BR (1) | BR9713975A (hu) |
| CA (1) | CA2274769A1 (hu) |
| CZ (1) | CZ219399A3 (hu) |
| EE (1) | EE9900258A (hu) |
| HU (1) | HUP0000397A3 (hu) |
| ID (1) | ID21763A (hu) |
| IL (1) | IL130485A0 (hu) |
| IS (1) | IS5056A (hu) |
| NO (1) | NO993066D0 (hu) |
| NZ (1) | NZ336025A (hu) |
| PL (1) | PL334012A1 (hu) |
| SE (1) | SE9604751D0 (hu) |
| SK (1) | SK82699A3 (hu) |
| TR (1) | TR199901413T2 (hu) |
| WO (1) | WO1998027987A1 (hu) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20140097446A (ko) | 2006-11-20 | 2014-08-06 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 통증 및 소양증 치료용 방법, 조성물 및 키트 |
| WO2010071865A1 (en) | 2008-12-19 | 2010-06-24 | Nuon Therapeutics, Inc. | Pharmaceutical compositions and methods for treating hyperuricemia and related disorders |
| US20100160351A1 (en) * | 2008-12-19 | 2010-06-24 | Nuon Therapeutics, Inc. | Pharmaceutical compositions and methods for treating hyperuricemia and related disorders |
| EP3485881B1 (en) | 2009-07-10 | 2024-03-13 | President and Fellows of Harvard College | Permanently charged sodium and calcium channel blockers as anti-inflammatory agents |
| WO2011032175A1 (en) | 2009-09-14 | 2011-03-17 | Nuon Therapeutics, Inc. | Combination formulations of tranilast and allopurinol and methods related thereto |
| WO2012112969A1 (en) | 2011-02-18 | 2012-08-23 | Endo Pharmaceuticals Inc. | Aminoindane compounds and use thereof in treating pain |
| HUE032240T2 (hu) | 2011-10-24 | 2017-09-28 | Asana Biosciences Llc | Ciklohexilaminok |
| AU2014365823B2 (en) | 2013-12-16 | 2019-05-02 | Abs Development 1, Inc. | P2X3 and/or P2X2/3 compounds and methods |
| JP6833811B2 (ja) | 2015-08-03 | 2021-02-24 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 荷電イオンチャネル遮断薬及び使用方法 |
| JP2016193937A (ja) * | 2016-08-09 | 2016-11-17 | 株式会社エヌ・エル・エー | 関節痛緩和組成物および機能性食品、並びに発酵ショウガ及びその製造方法 |
| KR20190053963A (ko) | 2016-09-30 | 2019-05-20 | 아사나 바이오사이언시스 엘엘씨 | P2x3 및/또는 p2x2/3 화합물 및 방법 |
| US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| US10828287B2 (en) | 2019-03-11 | 2020-11-10 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| WO2020185881A1 (en) | 2019-03-11 | 2020-09-17 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| CA3129089A1 (en) | 2019-03-11 | 2020-09-17 | Bridget Mccarthy Cole | Ester substituted ion channel blockers and methods for use |
| US11377422B2 (en) | 2019-03-11 | 2022-07-05 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
| EP4054586A4 (en) | 2019-11-06 | 2023-11-22 | Nocion Therapeutics, Inc. | CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE |
| JP2023500891A (ja) | 2019-11-06 | 2023-01-11 | ノシオン セラピューティクス，インコーポレイテッド | 荷電したイオンチャンネル遮断薬および使用方法 |
| WO2021183639A1 (en) | 2020-03-11 | 2021-09-16 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8903914D0 (sv) | 1989-11-22 | 1989-11-22 | Draco Ab | Oral composition for the treatment of inflammatory bowel diseases |
| GR1001529B (el) * | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης. |
| CA2140660A1 (en) * | 1993-06-13 | 1994-12-22 | Uwe R. Juergens | Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| US5840332A (en) * | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
-
1996
- 1996-12-20 SE SE9604751A patent/SE9604751D0/xx unknown
-
1997
- 1997-12-16 EE EEP199900258A patent/EE9900258A/xx unknown
- 1997-12-16 WO PCT/SE1997/002124 patent/WO1998027987A1/en not_active Application Discontinuation
- 1997-12-16 KR KR1019997005573A patent/KR20000069594A/ko not_active Application Discontinuation
- 1997-12-16 IL IL13048597A patent/IL130485A0/xx unknown
- 1997-12-16 US US09/011,623 patent/US6432937B1/en not_active Expired - Fee Related
- 1997-12-16 BR BR9713975-0A patent/BR9713975A/pt not_active IP Right Cessation
- 1997-12-16 EP EP97951366A patent/EP0957922A1/en not_active Withdrawn
- 1997-12-16 TR TR1999/01413T patent/TR199901413T2/xx unknown
- 1997-12-16 PL PL97334012A patent/PL334012A1/xx unknown
- 1997-12-16 SK SK826-99A patent/SK82699A3/sk unknown
- 1997-12-16 NZ NZ336025A patent/NZ336025A/en unknown
- 1997-12-16 AU AU55025/98A patent/AU5502598A/en not_active Abandoned
- 1997-12-16 HU HU0000397A patent/HUP0000397A3/hu unknown
- 1997-12-16 CZ CZ992193A patent/CZ219399A3/cs unknown
- 1997-12-16 JP JP52868498A patent/JP2001507024A/ja active Pending
- 1997-12-16 ID IDW990480A patent/ID21763A/id unknown
- 1997-12-16 CA CA002274769A patent/CA2274769A1/en not_active Abandoned
-
1999
- 1999-05-27 IS IS5056A patent/IS5056A/is unknown
- 1999-06-21 NO NO993066A patent/NO993066D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU5502598A (en) | 1998-07-17 |
| BR9713975A (pt) | 2000-04-11 |
| NO993066L (no) | 1999-06-21 |
| IS5056A (is) | 1999-05-27 |
| US6432937B1 (en) | 2002-08-13 |
| EE9900258A (et) | 1999-12-15 |
| HUP0000397A2 (hu) | 2000-10-28 |
| NZ336025A (en) | 2001-02-23 |
| CA2274769A1 (en) | 1998-07-02 |
| TR199901413T2 (xx) | 1999-08-23 |
| JP2001507024A (ja) | 2001-05-29 |
| WO1998027987A1 (en) | 1998-07-02 |
| PL334012A1 (en) | 2000-01-31 |
| CZ219399A3 (cs) | 1999-09-15 |
| SE9604751D0 (sv) | 1996-12-20 |
| NO993066D0 (no) | 1999-06-21 |
| EP0957922A1 (en) | 1999-11-24 |
| IL130485A0 (en) | 2000-06-01 |
| SK82699A3 (en) | 2000-02-14 |
| ID21763A (id) | 1999-07-22 |
| KR20000069594A (ko) | 2000-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0000397A3 (en) | The use of glucocorticoid substances pasessing a minimal systemic effect for producing pharmaceutical composition for the treatment of joint inflammation | |
| AU3548795A (en) | Benzopyranopyrazolyl derivatives for the treatment of inflammation | |
| IL174082A0 (en) | Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use for the preparation of a pharmaceutical composition | |
| AU3265695A (en) | Novel naphthyridine derivative and medicinal composition thereof | |
| AU2109195A (en) | Two-component device for the administration of drugs | |
| AU2027695A (en) | Pharmaceutical composition for treating stoma-peripheral inflammation diseases | |
| AUPO727097A0 (en) | Method of treatment of hepatoma and pharmaceutical compositions for use therein | |
| IL125446A0 (en) | Pharmaceutical composition for the treatment of asthma allergy and inflammation | |
| AU1897199A (en) | Use of formoterol in medicament for inflammation/allergy in upper airways | |
| AU1774097A (en) | Pharmaceutical compositions for the treatment of rhinitis | |
| IL113263A0 (en) | Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases | |
| AU2424895A (en) | Substituted spirodienes for the treatment of inflammation | |
| AU2753095A (en) | Triterpene derivative and medicinal composition | |
| HUP0001486A3 (en) | Pharmaceutical composition for topical use cantaining nimesulide gel systems and process for preparation thereof | |
| AU7042796A (en) | Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases | |
| AU5103196A (en) | Form of administration for applying pharmaceutical substances and auxiliary substances, and process for the preparation thereof | |
| IL126539A0 (en) | New pregnane derivatives with no alpha-17 substituent their medicinal use manufacturing method and their intermediates and related compounds | |
| AU2587195A (en) | Growth hormone therapy and related methods and pharmaceutical compositions | |
| AU4137596A (en) | Method for the treatment of periodontal disease and a pharmaceutical composition useful in said method | |
| GB9518553D0 (en) | New urea derivatives processes for the preparation thereof and pharmaceutical composition comprising the same | |
| GB9606579D0 (en) | Pharmaceutical composition and methods for the manufacture thereof | |
| AU3567995A (en) | Steroid esters and amides, method for their preparation and their pharmaceutical use | |
| AUPN766496A0 (en) | Method and composition for the potentiation of anti-inflammatory drugs | |
| GB2296496B (en) | Pharmaceutical pregnane derivatives | |
| AU5844796A (en) | Fused benzodiazepinone derivatives and medicinal composition of the same |